Connected Drug Delivery Devices Market - By Device, By Technology, By Application, By End-use & Forecast, 2023

Description

List of Tables

Connected Drug Delivery Devices Market is anticipated to garner substantial gains through 2032 owing to the increasing adoption of technologies such as machine learning and artificial intelligence (AI) in healthcare and drug delivery. Besides, the rising importance of real-time data across the healthcare sector will propel the market expansion. In addition, numerous initiatives taken up by market players to incorporate advanced technology in devices will promote the business growth.

Beckton Dickinson (BD), for instance, inked a deal with Biocorp to leverage its near-field communication tags in injectable devices. The deal would see Biocorp's Injay device incorporated in UltraSafePlus prefilled syringes, offering them increased digital connectivity that can be used to accumulate information such as injection time and date, batch number, and expiration date.

Overall, the connected drug delivery devices industry is segmented in terms of device, technology, application, end-use and region.

Based on devices, the integrated devices segment will showcase considerable growth during 2023-2032. The increasing prevalence of chronic diseases, rising awareness regarding health and illness, rising telecommunication industry, and surging government initiatives will propel the market expansion during the ensuing years.

Considering the technology, the Wi-Fi technology segment is anticipated to depict over 28.5% CAGR through 2032. Constant innovations have resulted in the increasing adoption of the latest technologies in medical devices. Besides, the rising consumer awareness regarding several connected drug delivery device technologies to track their daily medication will further drive the demand for WiFi embed connected drug delivery devices.

By application, the anaphylaxis segment accounted for more than USD 31 million in 2022. The segment will see huge growth owing to the increasing use of connected drug delivery devices in anaphylaxis patients for quick drug administration. Increasing cases of anaphylaxis would further benefit the overall market growth. European data depicted that the incidence rates for all-causes of anaphylaxis vary between 1.5 to 7.9 per 100,000 person per year.

In terms of end-use, the homecare settings segment held a considerable market share in 2022. Constant device development have made their use easy and convenient. Furthermore, an increasing preference for self-administered therapy at homecare will drive the industry growth.

Geographically, the Asia Pacific connected drug delivery devices market will grow throughout the forecast period. The constantly increasing pharmaceutical industry will assist the market progression as it offers lucrative opportunities for new and advanced products. Besides, the increasing adoption of new technologies and rising government initiatives for supporting the growth of the pharma industry will boost market development.

Product Code: 4422

Chapter 1 Methodology & Scope

1.1 Methodology
1.2 Market scope and definitions
1.3 Base estimates and working
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
- 1.7.1 Primary
- 1.7.2 Secondary
  - 1.7.2.1 Paid sources
  - 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Connected drug delivery devices market industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Device type trends
- 2.1.3 Technology trends
- 2.1.4 Application trends
- 2.1.5 End-use trends
- 2.1.6 Regional trends

Chapter 3 Connected Drug Delivery Devices Market Industry Insights

3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032
3.3 Industry impact forces
- 3.3.1 Growth drivers
  - 3.3.1.1 Rising patient awareness about adherence to prescribed therapies
  - 3.3.1.2 Rapidly moving healthcare IT infrastructure
  - 3.3.1.3 Soaring adoption of machine learning, and artificial intelligence (AI)
  - 3.3.1.4 Rising implementation of telehealth platform integrated with AR/VR technologies
- 3.3.2 Industry pitfalls & challenges
  - 3.3.2.1 Security concerns regarding patient data
  - 3.3.2.2 High price of the device
3.4 Growth potential analysis
- 3.4.1 By device type
- 3.4.2 By technology
- 3.4.3 By application
- 3.4.4 By end-use
3.5 COVID-19 impact analysis
3.6 Regulatory landscape
- 3.6.1 U.S,
- 3.6.2 Europe
- 3.6.3 Asia
  - 3.6.3.1 China
  - 3.6.3.2 Japan
  - 3.6.3.3 India
3.7 Technology landscape
3.8 Reimbursement scenario
3.9 Porter's analysis
3.10 PESTEL analysis

Chapter 4 Competitive Landscape

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic outlook matrix
4.7 Strategy dashboard

Chapter 5 Connected Drug Delivery Devices Market, By Device Type

5.1 Key device type trends
5.2 Connected sensors
- 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.2.2 Connected inhalation sensors
  - 5.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.2.3 Connected injectable sensors
  - 5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Integrated devices
- 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.3.2 Integrated inhalation devices
  - 5.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.3.3 Integrated injectable devices
  - 5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 Connected Drug Delivery Devices Market, By Technology

6.1 Key technology trends
6.2 Bluetooth
- 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Near Field Communication
- 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Wi-Fi
- 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Connected Drug Delivery Devices Market, By Application

7.1 Key application trends
7.2 Anaphylaxis
- 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Respiratory
- 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4 Cardiovascular
- 7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.5 Diabetes
- 7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.6 Hormone replacement
- 7.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.7 Others
- 7.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8 Connected Drug Delivery Devices Market, By End-use

8.1 Key end-use trends
8.2 Hospital
- 8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.3 Clinics
- 8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.4 Homecare settings
- 8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.5 Others
- 8.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9 Connected Drug Delivery Devices Market, By Region

9.1 Key regional trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Italy
- 9.3.5 Spain
- 9.3.6 Poland
- 9.3.7 Switzerland
- 9.3.8 Netherlands
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Thailand
- 9.4.7 Indonesia
- 9.4.8 Vietnam
9.5 Latin America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Columbia
- 9.5.4 Mexico
- 9.5.5 Peru
9.6 MEA
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 Israel
- 9.6.4 UAE

Chapter 10 Company Profiles

10.1 Adherium
10.2 Bayer AG
10.3 BioCorp Production
10.4 Findair Sp. z o. o.
10.5 Merck
10.6 Nemera
10.7 Phillips Medisize
10.8 Propeller Health
10.9 Teva Pharmaceuticals
10.10 West Pharmaceutical Services